Advertisement

Topics

Search Results for "Odac Marqibo 2012"

17:35 EDT 27th May 2017 | BioPortfolio

Matching Channels

macitentan

Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Coronavirus

Coronavirus were first identified in the 1960s, and were named after the crown-like projections on the surface of the virus. They cause respiratory infections in both humans and animals. Coronavir...

Veregen

Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...

PATHSEEK

Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships be...

Matching News

Puma rises after ODAC vote favors neratinib approval

Genentech’s subcutaneous rituximab gets unanimous FDA panel backing for certain blood cancers

The Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) voted unanimously (11…

Oncologic Drugs Advisory Committee Roster

This page contains the ODAC roster, which lists the current members and the current number of vacancies for the committee.

FDA advisory panel recommends approval of Epogen/Procrit biosimilar

The US Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) recommended approval…

FDA advisory committee to review Puma’s NDA for neratinib

The US Food and Drug Administration (FDA) has scheduled Puma Biotechnology’s New Drug Application (NDA) for neratinib for discussion by the Oncologic Drugs Advisory Committee (ODAC) on 24 May 2017.

FDA panel recommends Pfizer’s epoetin alfa biosimilar to treat anemia

The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recommended the approval of Pfizer's biosimilar to Amgen’s anemia drug Epogen (epoetin alfa) across all in...

Age-Specific Contribution of ART to Overall US Births, 2012-2014

This study uses US Centers for Disease Control and Prevention surveillance data to estimate the proportion of live births attributable to assisted reproductive technology by maternal age in the United...

J&J: drug price rises below 10% since 2012

Johnson & Johnson has published a “transparency report” showing the company kept drug price increases below 10% on average each year since 2012, in response to president Donald Trump’s criti...

Matching PubMed Articles

Assessment of 2012 EULAR/ACR new classification criteria for polymyalgia rheumatica in Japanese patients diagnosed using Bird's criteria.

The 2012 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for polymyalgia rheumatica (PMR) were published in 2012. The present study aimed to a...

Use of acupuncture in the USA: changes over a decade (2002-2012).

The use of acupuncture has gained popularity in the USA. The number of acupuncture users and licensed acupuncturists increased by 50% and 100%, respectively, between 2002 and 2012, coinciding with inc...

The Timing of Pertussis Cases in Unvaccinated Children in an Outbreak Year: Oregon 2012.

To assess whether, during a 2012 pertussis outbreak, unvaccinated and poorly vaccinated cases occurred earlier on a community level.

Hypoplastic Left Heart Syndrome: Exploring a Paradigm Shift in Favor of Surgery.

We hypothesized that enthusiasm for surgery increased for infants with hypoplastic left heart syndrome (HLHS) at Columbia University Medical Center (CUMC) between 1995 and 2012. We sought to identify ...

Characterization of clinical isolates of Mycobacterium tuberculosis from HIV positive individuals in Colombia, 2012.

One third of the increase in tuberculosis cases is attributed to the spread of HIV. In 2012, 1,397 HIV-associated tuberculosis cases were reported in Colombia, i.e., 11.8% of the total cases. Molecula...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement